ClinicalTrialsFinder

Resectable Colon Cancer Clinical Trials in Huzhou, Zhejiang

1 recruitingHuzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Unresectable Colon Cancer Peritoneal MetastasesPMMR/Ras/BRAF Wild-type
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT05742425